Cannabis could help control inflammation of the mouth and throat
Burning mouth syndrome is seen most often in postmenopausal women. Burning mouth syndrome is a temporary discomfort that many people experience after ingesting acidic or irritating foods. Anyone who has ever had a hot piece of pizza knows the burning sensation on the palate and / or tongue. It can be incredibly painful, and the pain and irritation can linger for several days. For most of us, the pain will eventually subside, and there are various over-the-counter treatments and home remedies to help ease the discomfort. Unfortunately, a small number of people around the world have to deal with pain all the time, regardless of what they eat.
What is burning mouth syndrome?
This is a disease known as “SBB”. The burning sensation, in addition to other symptoms such as permanent loss of taste, which seems to occur for no known reason. People who have this condition report that the burning sensation or other symptoms appear suddenly and in some cases can be very severe, as if the person has been drinking boiling water. However, burning mouth syndrome is rare and does not appear to affect people under the age of 30.
The most common treatments and mitigation strategies for this condition include drinking fluids, smoking, drinking alcohol, and not eating spicy foods.
According to a recent study, the cannabis plant may be able to successfully treat this disease, which is good news for patients with burnt mouth syndrome.
Cannabis as a treatment for burning mouth syndrome
A team of researchers in Italy has recently studied the relationship between cannabis and burning mouth syndrome (SBB) to see if the cannabis plant could serve as an effective treatment. Specifically, the researchers administered cannabis extracts to study participants (1 gram of extracts per 10 grams of olive oil).
The initial dose was one drop (∼1,22 mg THC and 0,02 mg CBD) per day with subsequent increases depending on symptoms. The fibromyalgia impact questionnaire (FIQ) was applied at the times before and after the intervention and at five visits over eight weeks.
“The subjects showed a statistically significant improvement over time in terms of clinical remission of oral symptoms… No serious reactions were detailed. None of the patients had to stop treatment because of side effects, ”the study authors reported.
In this pilot evaluation, the cannabis sativa oil provided was effective and well tolerated in patients with primary SBB. Other larger and well-defined randomized controlled trials, with different therapeutic approaches or a placebo control, are however necessary ”, concluded the authors of the study. There were no significant differences in the baseline FIQ (Questionnaire on the Impact of Fibromyalgia) score between the groups. However, after the intervention, the cannabis group exhibited a significant decrease in the FIQ score compared to the placebo group and compared to the baseline score of the cannabis group. By analyzing isolated items from the FIQ, the cannabis group showed a significant improvement in the scores “well-being”, “pain”, “doing work” and “fatigue”. The placebo group showed a significant improvement in the “depression” score after the intervention. There were no intolerable side effects.
Phytocannabinoids can be an inexpensive, well-tolerated therapy for reducing symptoms and improving quality of life patients with fibromyalgia. Future studies are still needed to assess long-term benefits, and studies with different varieties of cannabinoids associated with a withdrawal period should be conducted to improve our knowledge of the action of cannabis in this health problem.